Prospective Registry Of MultiPlex Testing (PROMPT)
https://www.facingourrisk.org/research-clinical-trials/study/50/prompt
Clinicaltrials.gov identifier:
NCT02665195 (https://clinicaltrials.gov/show/NCT02665195)
Study Contact Information:
The study is being conducted by researchers at University of Pennsylvania, Dana-Farber Cancer Center, Memorial Sloan Kettering and Mayo Clinic. You can contact the study team via email or by visiting the study website. You do not have to be a patient at the lead institutions to enroll.
About the Study
PROMPT is an online research registry for people who have had genetic panel testing (also known as multiplex testing) — a newer form of genetic testing that looks for mutations in several different genes at once. All genes on the panels have been linked to an increased risk of cancer, but some risks are better known than others.
The goal of the PROMPT Registry is to follow people with mutations or variants in genes on these panels, so that patients, physicians, and researchers can more clearly understand these lesser-known risks. For more information visit the PROMPT Study website.
This study is no longer enrolling people.
This Study is Open To:
This study is no longer enrolling people.
This Study is Not Open To:
This study is no longer enrolling people.
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.